Alzamend Neuro ALZN
NASDAQ ALZN
$1.78 -0.04 (-2.14%)
As of: Sep 30, 2026 · 12:33 PM EDT

Alzamend Neuro, Inc. (ALZN) EBIT (2020 - 2026)

Updated

Alzamend Neuro (ALZN) reported EBIT of -$3.03 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$2.7 million a year earlier.

Analysis

Alzamend Neuro, Inc. (ALZN) EBIT (2020 - 2026) Analysis & Trends

Over the twelve months ended Jul 31, 2026, Alzamend Neuro's EBIT came in at -$9.09 million; for FY2026 (ended Apr 30, 2026), it came in at -$8.77 million.

  • By fiscal year, EBIT came in at -$4.5 million in FY2025, -$9.94 million in FY2024, -$14.87 million in FY2023 and -$12.32 million in FY2022.
  • The fiscal Q1 2027 figure ranks as the lowest quarterly EBIT since fiscal Q1 2024.
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -$2.87 million (Q4 2026), -$2.2 million (Q3 2026) and -$998,109 (Q2 2026).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -3.03 Mn
Apr 30, 2026 -2.87 Mn
Jan 31, 2026 -2.20 Mn
Oct 31, 2025 -998,109.00
Jul 31, 2025 -2.70 Mn
Apr 30, 2025 -1.14 Mn
Jan 31, 2025 -1.04 Mn
Oct 31, 2024 -1.36 Mn
Jul 31, 2024 -962,405.00
Apr 30, 2024 -850,064.00
Jan 31, 2024 -2.66 Mn
Oct 31, 2023 -2.90 Mn
Jul 31, 2023 -3.53 Mn
Apr 30, 2023 -3.31 Mn
Jan 31, 2023 -5.42 Mn
Oct 31, 2022 -3.11 Mn
Jul 31, 2022 -3.04 Mn
Apr 30, 2022 -3.87 Mn
Jan 31, 2022 -2.56 Mn
Oct 31, 2021 -3.58 Mn
API Access

Alzamend Neuro, Inc. EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ALZN&period=max&api_key=YOUR_API_KEY